CS255875B1 - Process for preparing new derivatives of 2-halogennicergoline - Google Patents

Process for preparing new derivatives of 2-halogennicergoline Download PDF

Info

Publication number
CS255875B1
CS255875B1 CS864584A CS458486A CS255875B1 CS 255875 B1 CS255875 B1 CS 255875B1 CS 864584 A CS864584 A CS 864584A CS 458486 A CS458486 A CS 458486A CS 255875 B1 CS255875 B1 CS 255875B1
Authority
CS
Czechoslovakia
Prior art keywords
acid
mmol
nicergoline
formula
preparation
Prior art date
Application number
CS864584A
Other languages
Czech (cs)
English (en)
Inventor
Gabor Megyeri
Tibor Keve
Bela Stefko
Erik Bogsch
Janos Galambos
Anna Kassai
Ferenc Trischler
Eva Palosi
Dora Groo
Egon Karpati
Zsolt Szombathelyi
Laszlo Szporny
Bela Kiss
Istvan Laszlovszky
Erzsebet Lapis
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of CS255875B1 publication Critical patent/CS255875B1/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS864584A 1985-06-21 1986-06-20 Process for preparing new derivatives of 2-halogennicergoline CS255875B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852447A HU193782B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof

Publications (1)

Publication Number Publication Date
CS255875B1 true CS255875B1 (en) 1988-03-15

Family

ID=10959403

Family Applications (1)

Application Number Title Priority Date Filing Date
CS864584A CS255875B1 (en) 1985-06-21 1986-06-20 Process for preparing new derivatives of 2-halogennicergoline

Country Status (30)

Country Link
US (1) US4753949A (es)
JP (1) JPS62485A (es)
CN (1) CN1015365B (es)
AR (1) AR241533A1 (es)
AT (1) AT390614B (es)
AU (1) AU594686B2 (es)
BE (1) BE904957A (es)
CH (1) CH671018A5 (es)
CS (1) CS255875B1 (es)
DD (1) DD246111A5 (es)
DE (1) DE3620647A1 (es)
DK (1) DK292086A (es)
ES (1) ES8800953A1 (es)
FI (1) FI84605C (es)
FR (1) FR2583756B1 (es)
GB (1) GB2176788B (es)
HU (1) HU193782B (es)
IL (1) IL79179A0 (es)
IN (1) IN163116B (es)
IT (1) IT1204865B (es)
LU (1) LU86485A1 (es)
NL (1) NL8601612A (es)
NO (1) NO164099C (es)
PH (1) PH24732A (es)
PL (1) PL147390B1 (es)
PT (1) PT82808B (es)
SE (1) SE463716B (es)
SU (1) SU1445557A3 (es)
YU (1) YU107986A (es)
ZA (1) ZA864633B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193781B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228943A (en) * 1962-06-11 1966-01-11 Lumilysergol derivatives
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
GB1513322A (en) * 1976-01-09 1978-06-07 Farmaceutici Italia Heterocyclic ergoline derivatives
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
EP0091652B1 (en) * 1982-04-13 1986-02-26 FARMITALIA CARLO ERBA S.p.A. Ergoline derivatives, process for producing the ergoline derivatives and pharmaceutical compositions containing them
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives

Also Published As

Publication number Publication date
ATA168486A (de) 1989-11-15
GB2176788A (en) 1987-01-07
PH24732A (en) 1990-10-01
PT82808B (pt) 1988-04-21
FR2583756B1 (fr) 1990-01-12
CN1015365B (zh) 1992-02-05
DD246111A5 (de) 1987-05-27
US4753949A (en) 1988-06-28
NO164099C (no) 1990-08-29
AR241533A1 (es) 1992-08-31
DK292086D0 (da) 1986-06-20
ES8800953A1 (es) 1987-12-16
SE463716B (sv) 1991-01-14
LU86485A1 (de) 1986-12-02
PL147390B1 (en) 1989-05-31
NO862493L (no) 1986-12-22
SU1445557A3 (ru) 1988-12-15
DK292086A (da) 1986-12-22
AT390614B (de) 1990-06-11
BE904957A (fr) 1986-12-19
SE8602737L (sv) 1986-12-22
HU193782B (en) 1987-11-30
FI862635A (fi) 1986-12-22
IL79179A0 (en) 1986-09-30
IT1204865B (it) 1989-03-10
GB8615120D0 (en) 1986-07-23
DE3620647A1 (de) 1987-01-02
FI84605B (fi) 1991-09-13
JPH0529227B2 (es) 1993-04-28
FR2583756A1 (fr) 1986-12-26
NO164099B (no) 1990-05-21
IT8620873A0 (it) 1986-06-20
FI84605C (fi) 1991-12-27
HUT41024A (en) 1987-03-30
CH671018A5 (es) 1989-07-31
GB2176788B (en) 1989-07-26
ZA864633B (en) 1987-02-25
JPS62485A (ja) 1987-01-06
SE8602737D0 (sv) 1986-06-19
AU5891686A (en) 1986-12-24
NL8601612A (nl) 1987-01-16
IN163116B (es) 1988-08-13
PT82808A (en) 1986-07-01
ES556359A0 (es) 1987-12-16
FI862635A0 (fi) 1986-06-19
NO862493D0 (no) 1986-06-20
YU107986A (en) 1988-04-30
CN86104086A (zh) 1986-12-17
AU594686B2 (en) 1990-03-15

Similar Documents

Publication Publication Date Title
DK167573B1 (da) Faste former af 2-ethoxy-4-oen-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethylaa-benzoesyre, laegemidler indeholdende disse former, fremgangsmaade til fremstilling af de faste former, samt fremgangsmaade til fremstilling af et laegemiddel
KR910006986B1 (ko) 치환된 5,11-디하이드로-6H-디벤즈[b,e]아제핀-6-온의 제조방법
CZ200471A3 (cs) Způsob purifikace N-[3-(3-kyanopyrazol[1,5-a]pyrimidin-7-yl)fenyl]-N-ethylacetamidu (zaleplon) a krystalické formy zaleplonu připravitelné tímto způsobem
NO172939B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive estere av estramustin
JPH0150698B2 (es)
CZ419291A3 (en) Benzene derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
CS255875B1 (en) Process for preparing new derivatives of 2-halogennicergoline
EP0665228A1 (de) Neue 3-Phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen enthaltende Arzneimittel
KR100659927B1 (ko) 다형태를갖는독사조신메실레이트의새로운형태(제iii형)
US4299836A (en) Novel ergol-8-ene and ergolin compounds and process for preparing same
JP2694553B2 (ja) ２０，２１‐ジノルエブルナメニンの新規の置換誘導体、それらの製造方法及び得られる新規の中間体、それらの薬剤としての使用並びにそれらを含有する製薬組成物
US7521472B2 (en) Crystal of two-ring heterocyclic sulfonamide compound
EP0085893B1 (de) Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
KR880001280B1 (ko) 2-할로니세르골린 유도체와 그 산부가염의 제조방법
EP0152799B1 (en) Compounds having peripheral calcium antagonist, anticonvulsive and eumetabolic activity, processes for the preparation thereof and pharmaceutical compositions containing them
EP0101633B1 (en) Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
JPS5810387B2 (ja) ４，５，６，７テトラヒドロイミダゾ〔４，５−ｃ〕ピリジン誘導体及びその製法
EP0367944A2 (en) Ether derivative of 4-[3H] -quinazolinone, a process for the preparation thereof, and pharmaceutical compositions
NO152750B (no) Fremgangsmaate for fremstilling av nitrogen brohode-kondenserte pyrimidinforbindelser
US20030176401A1 (en) Sodium salt of an azo derivative of 5-aminosalicylic acid
CS255876B2 (en) Process for preparing new 10 alpha-methoxy-6-methyl-ergolines
CS219363B1 (cs) Estery kyseliny N-[(5R,8S,10R)-6-propyl-8-ergolinyllkarbamové a způsoby jejich výroby